CBB1007 trihydrochloride - ≥96% , CAS No.2070015-03-9

CAS: 2070015-03-9 Cat. No.: C650396 Molecular Weight: 643.99
AVAILABLE TO ORDER
GRADE & PURITY ≥96%
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
2mg
C650396-2mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$310.90
5mg
C650396-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$465.90
10mg
C650396-10mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$706.90
50mg
C650396-50mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,674.90
100mg
C650396-100mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$2,604.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥96% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C,Desiccated Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).IC50 Value: 5.27 uMTarget: hLSD1CBB1007 efficiently can block LSD1-mediated demethylation of H3K4Me2 and H3K4Me (IC50 ≤ 5 μM) with no effect on H3K4Me3 and H3K9Me2, and LSD2 and JARID1A activities. Increases H3K4Me2 and H3K4Me contents (IC50 ≤ 5 μM), and causes activation of epigenetically suppressed CHRM4/M4-ArchR and SCN3A genes in F9 cells (IC50 ≤ 3.74 μM). CBB1007 was Shown to preferentially arrest the growth of pluripotent tumors with minimal effect on non-pluripotent cancer or normal somatic cells (IC50 ≥ 100 μM).

Form:Solid

IC50& Target:KDM1/LSD1

Specifications

Specifications & Purity
≥96%
Biochemical and Physiological Mechanisms
CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).\nIC50 Value: 5.27 uM\nTarget: hLSD1\nCBB1007 efficiently can block L
Storage
Store at 2-8°C, Desiccated
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥96%
Names and Identifiers
Molecular Weight 643.99

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilityDMSO : 25 mg/mL (38.82 mM; ultrasonic and warming and heat to 80°C)
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.